| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
|
Shore, Neal
|
|
|
21 |
2 |
p. 278-285
|
artikel
|
| 2 |
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
|
Makrakis, Dimitrios
|
|
|
21 |
2 |
p. 265-272
|
artikel
|
| 3 |
ATR Inhibition in Advanced Urothelial Carcinoma
|
Leibrandt, Ryan C.
|
|
|
21 |
2 |
p. 203-207
|
artikel
|
| 4 |
Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG
|
Hald, Oliver C.
|
|
|
21 |
2 |
p. e70-e77
|
artikel
|
| 5 |
Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience
|
Jang, Albert
|
|
|
21 |
2 |
p. e9-e18
|
artikel
|
| 6 |
Demographic Profiles and Survival Outcomes of Patients With Urachal Adenocarcinoma: A Rare Tumor of the Urachal Remnant
|
Bhargava, Prabhat
|
|
|
21 |
2 |
p. e44-e52
|
artikel
|
| 7 |
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly
|
Necchi, Andrea
|
|
|
21 |
2 |
p. 301-308
|
artikel
|
| 8 |
Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy
|
Nikitas, John
|
|
|
21 |
2 |
p. 208-212
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
21 |
2 |
p. A1
|
artikel
|
| 10 |
Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival
|
Qiang, Yuanyuan
|
|
|
21 |
2 |
p. e78-e91
|
artikel
|
| 11 |
Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States
|
Jonasch, Eric
|
|
|
21 |
2 |
p. 238-247
|
artikel
|
| 12 |
Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic
|
Stecca, Carlos E.
|
|
|
21 |
2 |
p. 273-277
|
artikel
|
| 13 |
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
|
Siltari, Aino
|
|
|
21 |
2 |
p. 316.e1-316.e11
|
artikel
|
| 14 |
Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis
|
Garg, Harshit
|
|
|
21 |
2 |
p. 314.e1-314.e7
|
artikel
|
| 15 |
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
|
Taza, Fadi
|
|
|
21 |
2 |
p. 213-220
|
artikel
|
| 16 |
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma
|
Panunzio, Andrea
|
|
|
21 |
2 |
p. 295-300
|
artikel
|
| 17 |
New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer
|
Ayyash, Omar
|
|
|
21 |
2 |
p. e1-e8
|
artikel
|
| 18 |
“Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil”
|
Jardim, Denis L.
|
|
|
21 |
2 |
p. e58-e69
|
artikel
|
| 19 |
Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma
|
Dizman, Nazli
|
|
|
21 |
2 |
p. 221-229
|
artikel
|
| 20 |
Prevalence and Natural History of Non-metastatic Castrate Resistant Prostate Cancer: A Population-Based Analysis
|
Hird, Amanda E.
|
|
|
21 |
2 |
p. e27-e34
|
artikel
|
| 21 |
PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CT
|
Pinot, Fanny
|
|
|
21 |
2 |
p. 248-257
|
artikel
|
| 22 |
Real World Data of Diagnosis, Survival, and Treatment Outcomes in Patients With Metastatic Non Clear Cell Renal Cell Carcinoma
|
Izarn, Floriane
|
|
|
21 |
2 |
p. e35-e43
|
artikel
|
| 23 |
Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature
|
Wang, Yiming
|
|
|
21 |
2 |
p. 309-313
|
artikel
|
| 24 |
Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer
|
Matsubara, Nobuaki
|
|
|
21 |
2 |
p. 230-237.e1
|
artikel
|
| 25 |
Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy
|
Huang, Jiwei
|
|
|
21 |
2 |
p. 315.e1-315.e7
|
artikel
|
| 26 |
Table of contents
|
|
|
|
21 |
2 |
p. A3-A8
|
artikel
|
| 27 |
Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals
|
Satir, Atilla
|
|
|
21 |
2 |
p. e53-e57
|
artikel
|
| 28 |
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
|
Makrakis, Dimitrios
|
|
|
21 |
2 |
p. 286-294
|
artikel
|
| 29 |
Uretero-enteric Strictures After Robot Assisted Radical Cystectomy: Prevalence and Management Over Two Decades
|
Ramahi, Yousuf O.
|
|
|
21 |
2 |
p. e19-e26
|
artikel
|
| 30 |
Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non–muscle-Invasive Bladder Cancer
|
Feiertag, Nathan
|
|
|
21 |
2 |
p. 258-264
|
artikel
|
Tijdschrift beschrijving